[ European Joint Programme on Rare Diseases (EJP RD) Call for Proposals 2019 - Research funding ]
Event details
Date | 15.02.2019 |
Category | Call for proposal |
European Joint Programme on Rare Diseases (EJP RD) Call for Proposals 2019: "Transnational research projects to accelerate diagnosis and/or explore disease progression and mechanisms of rare diseases”
The aim of the call is to enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project based on complementarities and sharing of expertise, with a clear benefit for patients.
Topic: Research projects to accelerate diagnosis and/or explore disease progression and mechanisms of rare diseases
Projects shall involve a group of rare diseases or a single rare disease following the European definition i.e. a disease affecting not more than five in 10.000 persons in the European Community, EC associated states and Canada. Applicants are encouraged to assemble groups of rare diseases based on solid criteria and commonalities if this leverages added value in sharing resources or expertise and has the capacity to elucidate common disease mechanisms and therapeutic targets.
General conditions for application
Joint research proposals may be submitted by applicants belonging to one of the following categories (according to country/regional regulations):
Please note that the inclusion of a non-eligible research partner (principle investigator) in a proposal leads to the rejection of the entire proposal without further review. Whilst applications will be submitted jointly by applicants from several countries/regions, individual groups will be funded by the individual funding organisation of their country/region that is participating in the EJPRD JTC 2019. The applications are therefore subjected to eligibility criteria of individual funding organisations. Applicants are strongly advised to contact their corresponding national/regional representative and confirm eligibility with their respective funding organisations in advance of submitting an application.
Only transnational projects will be funded. Each consortium submitting a proposal must involve a minimum of four eligible and a maximum of six eligible research partners from at least four different countries participating to the call (funding organisations list).
Timetable
There will be a two-stage submission procedure for joint applications: pre-proposals and full proposals. The call is scheduled to open on December 15, 2018.
The deadline for submitting the pre-proposals is February 15, 2019.
An independent international Scientific Evaluation Committee will carry out a scientific evaluation according to specific evaluation criteria. Based on this central evaluation, selected consortia will be invited to submit a full proposal by early May 2019 (indicative deadline for full proposals: June 11, 2019).
More information:
Joint Call 2019 Secretariat:
The aim of the call is to enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project based on complementarities and sharing of expertise, with a clear benefit for patients.
Topic: Research projects to accelerate diagnosis and/or explore disease progression and mechanisms of rare diseases
Projects shall involve a group of rare diseases or a single rare disease following the European definition i.e. a disease affecting not more than five in 10.000 persons in the European Community, EC associated states and Canada. Applicants are encouraged to assemble groups of rare diseases based on solid criteria and commonalities if this leverages added value in sharing resources or expertise and has the capacity to elucidate common disease mechanisms and therapeutic targets.
General conditions for application
Joint research proposals may be submitted by applicants belonging to one of the following categories (according to country/regional regulations):
- Academia (research teams working in universities, other higher education institutions or research institutes)
- Clinical/public health sector (research teams working in hospitals/public health and/or other health care settings and health organisations)
- Enterprise (all sizes of private companies). Participation of small and medium-size enterprises (SMEs) is encouraged when allowed by national/regional regulations
- Patient advocacy organisations (PAOs – see more information below and refer to the INSERM contact point)
Please note that the inclusion of a non-eligible research partner (principle investigator) in a proposal leads to the rejection of the entire proposal without further review. Whilst applications will be submitted jointly by applicants from several countries/regions, individual groups will be funded by the individual funding organisation of their country/region that is participating in the EJPRD JTC 2019. The applications are therefore subjected to eligibility criteria of individual funding organisations. Applicants are strongly advised to contact their corresponding national/regional representative and confirm eligibility with their respective funding organisations in advance of submitting an application.
Only transnational projects will be funded. Each consortium submitting a proposal must involve a minimum of four eligible and a maximum of six eligible research partners from at least four different countries participating to the call (funding organisations list).
Timetable
There will be a two-stage submission procedure for joint applications: pre-proposals and full proposals. The call is scheduled to open on December 15, 2018.
The deadline for submitting the pre-proposals is February 15, 2019.
An independent international Scientific Evaluation Committee will carry out a scientific evaluation according to specific evaluation criteria. Based on this central evaluation, selected consortia will be invited to submit a full proposal by early May 2019 (indicative deadline for full proposals: June 11, 2019).
More information:
- http://www.ejprarediseases.org/index.php/funding/
- http://www.erare.eu/joint-call/1st-joint-call-european-joint-programme-rare-diseases-jtc-2019
- National contact points
- Call document
Joint Call 2019 Secretariat:
- E-Mail: [email protected]
- Katarzyna Saedler, [email protected], +49 (0)228 3821 1947
- Michaela Fersch, [email protected], +49 (0)228 3821 1268
- Ralph Schuster, [email protected], +49 (0)228 3821 1233
Practical information
- General public
- Free